About KALM Therapeutics
KALM Therapeutics is a private company based in Huntsville, Alabama, incorporated in 2024 in Delaware. It has reported $590,380 raised in one offering on Form D since August 2024.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | Aug 9, 2024 | $590,380fully sold | 14 | $42,170 | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on KALM Therapeutics's Form D filed Aug 9, 2024.
CS
Chris Seibert
President and director
AS
Anuj Singhal
Executive officer and director